Details
Stereochemistry | RACEMIC |
Molecular Formula | C26H29N3O6 |
Molecular Weight | 479.525 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC(=O)C1=C(C)NC(C)=C(C1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
InChI
InChIKey=ZBBHBTPTTSWHBA-UHFFFAOYSA-N
InChI=1S/C26H29N3O6/c1-17-22(25(30)34-4)24(20-11-8-12-21(15-20)29(32)33)23(18(2)27-17)26(31)35-14-13-28(3)16-19-9-6-5-7-10-19/h5-12,15,24,27H,13-14,16H2,1-4H3
Molecular Formula | C26H29N3O6 |
Molecular Weight | 479.525 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:45:51 UTC 2023
by
admin
on
Fri Dec 15 15:45:51 UTC 2023
|
Record UNII |
CZ5312222S
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
C08CA04
Created by
admin on Fri Dec 15 15:45:51 UTC 2023 , Edited by admin on Fri Dec 15 15:45:51 UTC 2023
|
||
|
FDA ORPHAN DRUG |
712819
Created by
admin on Fri Dec 15 15:45:51 UTC 2023 , Edited by admin on Fri Dec 15 15:45:51 UTC 2023
|
||
|
NDF-RT |
N0000007556
Created by
admin on Fri Dec 15 15:45:51 UTC 2023 , Edited by admin on Fri Dec 15 15:45:51 UTC 2023
|
||
|
NCI_THESAURUS |
C333
Created by
admin on Fri Dec 15 15:45:51 UTC 2023 , Edited by admin on Fri Dec 15 15:45:51 UTC 2023
|
||
|
NDF-RT |
N0000175421
Created by
admin on Fri Dec 15 15:45:51 UTC 2023 , Edited by admin on Fri Dec 15 15:45:51 UTC 2023
|
||
|
WHO-VATC |
QC08CA04
Created by
admin on Fri Dec 15 15:45:51 UTC 2023 , Edited by admin on Fri Dec 15 15:45:51 UTC 2023
|
||
|
NDF-RT |
N0000000069
Created by
admin on Fri Dec 15 15:45:51 UTC 2023 , Edited by admin on Fri Dec 15 15:45:51 UTC 2023
|
||
|
LIVERTOX |
NBK548755
Created by
admin on Fri Dec 15 15:45:51 UTC 2023 , Edited by admin on Fri Dec 15 15:45:51 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C66879
Created by
admin on Fri Dec 15 15:45:51 UTC 2023 , Edited by admin on Fri Dec 15 15:45:51 UTC 2023
|
PRIMARY | |||
|
55985-32-5
Created by
admin on Fri Dec 15 15:45:51 UTC 2023 , Edited by admin on Fri Dec 15 15:45:51 UTC 2023
|
PRIMARY | |||
|
100000091443
Created by
admin on Fri Dec 15 15:45:51 UTC 2023 , Edited by admin on Fri Dec 15 15:45:51 UTC 2023
|
PRIMARY | |||
|
DTXSID6023363
Created by
admin on Fri Dec 15 15:45:51 UTC 2023 , Edited by admin on Fri Dec 15 15:45:51 UTC 2023
|
PRIMARY | |||
|
D009529
Created by
admin on Fri Dec 15 15:45:51 UTC 2023 , Edited by admin on Fri Dec 15 15:45:51 UTC 2023
|
PRIMARY | |||
|
SUB09225MIG
Created by
admin on Fri Dec 15 15:45:51 UTC 2023 , Edited by admin on Fri Dec 15 15:45:51 UTC 2023
|
PRIMARY | |||
|
N0000182140
Created by
admin on Fri Dec 15 15:45:51 UTC 2023 , Edited by admin on Fri Dec 15 15:45:51 UTC 2023
|
PRIMARY | Cytochrome P450 2C19 Inhibitors [MoA] | ||
|
1909
Created by
admin on Fri Dec 15 15:45:51 UTC 2023 , Edited by admin on Fri Dec 15 15:45:51 UTC 2023
|
PRIMARY | |||
|
DB00622
Created by
admin on Fri Dec 15 15:45:51 UTC 2023 , Edited by admin on Fri Dec 15 15:45:51 UTC 2023
|
PRIMARY | |||
|
4474
Created by
admin on Fri Dec 15 15:45:51 UTC 2023 , Edited by admin on Fri Dec 15 15:45:51 UTC 2023
|
PRIMARY | |||
|
2559
Created by
admin on Fri Dec 15 15:45:51 UTC 2023 , Edited by admin on Fri Dec 15 15:45:51 UTC 2023
|
PRIMARY | |||
|
N0000187062
Created by
admin on Fri Dec 15 15:45:51 UTC 2023 , Edited by admin on Fri Dec 15 15:45:51 UTC 2023
|
PRIMARY | Cytochrome P450 2C8 Inhibitors [MoA] | ||
|
CHEMBL1484
Created by
admin on Fri Dec 15 15:45:51 UTC 2023 , Edited by admin on Fri Dec 15 15:45:51 UTC 2023
|
PRIMARY | |||
|
m7850
Created by
admin on Fri Dec 15 15:45:51 UTC 2023 , Edited by admin on Fri Dec 15 15:45:51 UTC 2023
|
PRIMARY | Merck Index | ||
|
7396
Created by
admin on Fri Dec 15 15:45:51 UTC 2023 , Edited by admin on Fri Dec 15 15:45:51 UTC 2023
|
PRIMARY | RxNorm | ||
|
4745
Created by
admin on Fri Dec 15 15:45:51 UTC 2023 , Edited by admin on Fri Dec 15 15:45:51 UTC 2023
|
PRIMARY | |||
|
CZ5312222S
Created by
admin on Fri Dec 15 15:45:51 UTC 2023 , Edited by admin on Fri Dec 15 15:45:51 UTC 2023
|
PRIMARY | |||
|
259-932-3
Created by
admin on Fri Dec 15 15:45:51 UTC 2023 , Edited by admin on Fri Dec 15 15:45:51 UTC 2023
|
PRIMARY | |||
|
N0000182141
Created by
admin on Fri Dec 15 15:45:51 UTC 2023 , Edited by admin on Fri Dec 15 15:45:51 UTC 2023
|
PRIMARY | Cytochrome P450 3A4 Inhibitors [MoA] | ||
|
Nicardipine
Created by
admin on Fri Dec 15 15:45:51 UTC 2023 , Edited by admin on Fri Dec 15 15:45:51 UTC 2023
|
PRIMARY | |||
|
CZ5312222S
Created by
admin on Fri Dec 15 15:45:51 UTC 2023 , Edited by admin on Fri Dec 15 15:45:51 UTC 2023
|
PRIMARY | |||
|
N0000182137
Created by
admin on Fri Dec 15 15:45:51 UTC 2023 , Edited by admin on Fri Dec 15 15:45:51 UTC 2023
|
PRIMARY | Cytochrome P450 2D6 Inhibitors [MoA] | ||
|
NICARDIPINE
Created by
admin on Fri Dec 15 15:45:51 UTC 2023 , Edited by admin on Fri Dec 15 15:45:51 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
TARGET -> INHIBITOR | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
ROUTE OF ADMINISTRATION PHARMACOKINETIC |
|
||
Biological Half-life | PHARMACOKINETIC |
|
ROUTE OF ADMINISTRATION PHARMACOKINETIC |
|
||